Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

18 projects found matching your search criteria :

  1. Developmental neurotoxicity of nanoplastic. Functional, structural and molecular analysis of the neurovascular unit in t...

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Kamil Dawid Adamiak

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  2. Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Agnieszka Wnuk

    Instytut Farmakologii PAN

  3. Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Bernadeta Angelika Pietrzak-Wawrzyńska

    Instytut Farmakologii PAN

  4. Is "the plastic brain" a real threat? In search of neurotoxic mechanisms of plastic nanoparticles.

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Lidia Marta Strużyńska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  5. Strategies to protect against methamphetamine-induced neurotoxicity

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Michał Jan Toborek

    Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach, Instytut Fizjoterapii i Nauk o Zdrowiu

  6. Contribution of glutaminergic NMDA receptor to the mechanisms of nanosilver neurotoxicity in vivo

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Lidia Marta Strużyńska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  7. Pharmacological properties and neurotoxicity of novel NBOMe derivatives

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Krystyna Czesława Gołembiowska

    Instytut Farmakologii PAN

  8. Role of prion protein in amyloidogenesis and neurotoxicity of Tau protein

    Call: OPUS 11 , Panel: NZ4

    Principal investigator: dr hab. Krzysztof Nieznański

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  9. Neurodevelopmental patomechanisms of triclocarban- and dichlorodiphenyldichloroetylene-induced effects: the role of apop...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: dr hab. Małgorzata Kajta

    Instytut Farmakologii PAN

  10. Physical activity-mediated stimulation of neurogenesis in methamphetamine abuse

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: prof. Michał Jan Toborek

    Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach, Wydział Fizjoterapii

  11. miR-124 as a potential negative modulator of gfap gene expression in fish exposed to neurotoxin microcystin-LR

    Call: PRELUDIUM 8 , Panel: NZ9

    Principal investigator: Maciej Florczyk

    Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Nauk o Środowisku

  12. The mechanism of neurotoxic action of benzophenone-3

    Call: OPUS 8 , Panel: NZ7

    Principal investigator: prof. Bogusława Budziszewska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  13. Neurotoxic effects of benzophenone-3 : the role of estrogen receptors and retinoid X receptor alpha.

    Call: PRELUDIUM 7 , Panel: NZ4

    Principal investigator: Agnieszka Wnuk

    Instytut Farmakologii PAN

  14. Effect of caffeine on neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse brain.

    Call: PRELUDIUM 6 , Panel: NZ7

    Principal investigator: Anna Maria Górska

    Instytut Farmakologii PAN

  15. "Legal Higsh"- CNS effects and neurotoxicity

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: prof. Krystyna Czesława Gołembiowska

    Instytut Farmakologii PAN

  16. Molecular mechanisms of tetrabromobisphenol A neurotoxicity

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: prof. Jerzy Wiesław Łazarewicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  17. Evaluation of the protective capacity of resveratrol and quercetin in models of neurotoxicity induced by aluminum and ma...

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: dr Maciej Tadeusz Gawlik

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  18. Synthesis and marking the activity of new potential antagonists of receptors for excitatory amino acids which have the s...

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: prof. Aleksander Paweł Mazurek

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny